Bifidobacterium breve enhances transforming growth factor β1 signaling by regulating Smad7 expression in preterm infants

被引:80
作者
Fujii, Tohru [1 ]
Ohtsuka, Yoshikazu [1 ]
Lee, Tsubasa [1 ]
Kudo, Takahlro [1 ]
Shoji, Hiromichi [1 ]
Sato, Hiroaki [1 ]
Nagata, Satoru [1 ]
Shimizu, Toshiaki [1 ]
Yamashiro, Yuichiro [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Pediat & Adolescence Med, Bunkyo Ku, Tokyo 1138421, Japan
关键词
preterm infant; probiotics; Smad; TGF-beta; 1;
D O I
10.1097/01.mpg.0000228100.04702.f8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Transforming growth factor (TGF) beta 1 displays a broad spectrum of activities in mucosal regulation, including induction of oral tolerance, potent anti-inflammatory effects, mucosal IgA expression and effects on epithelial cell proliferation and differentiation. The present study examined the effect of probiotics on the immunologic system of preterm infants in relation to TGF-beta signaling. Methods: Subjects comprised 19 preterm infants divided into 2 groups: receiving Bifidobacterium breve supplementation (B. breve group) and without supplementation (controls). Blood samples were collected from both groups on days 0, 14 and 28 after birth. Serum cytokine levels were measured using enzyme-linked immunosorbent assay, and expression levels of the TGF-beta signaling molecule, Smad, were examined using semiquantitative reverse transcriptase-polymerase chain reaction. Results: Serum TGF-beta 1 level was elevated on day 14 and remained elevated on day 28 in the B. breve group. Level of messenger RNA expression was enhanced for Smad3 and reduced for Smad7 (antagonistic Smad) after B. breve administration relative to levels in controls on day 28. Conclusions: These results demonstrated that the administration of B. breve to preterm infants can up-regulate TGF-beta 1 signaling and may possibly be beneficial in attenuating inflammatory and allergic reactions in these infants.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 17 条
  • [1] Neonatal necrotizing enterocolitis: Possible role of probiotic supplementation
    Caplan, MS
    Jilling, T
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 30 : S18 - S22
  • [2] Immunity and probiotics
    Dugas, B
    Mercenier, A
    Lenoir-Wijnkoop, I
    Arnaud, C
    Dugas, N
    Postaire, E
    [J]. IMMUNOLOGY TODAY, 1999, 20 (09): : 387 - 390
  • [3] TGF-β/Smad signaling defects in inflammatory bowel disease:: mechanisms and possible novel therapies for chronic inflammation
    Fiocchi, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (04) : 523 - 526
  • [4] Immunonutrients and neonates
    Huang, Y
    Shao, XM
    Neu, J
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (03) : 122 - 128
  • [5] Early administration of Bifidobacterium breve to preterm infants: Randomised controlled trial
    Kitajima, H
    Sumida, Y
    Tanaka, R
    Yuki, N
    Takayama, H
    Fujimura, M
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1997, 76 (02): : F101 - F107
  • [6] Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants
    Li, YD
    Shimizu, T
    Hosaka, A
    Kaneko, N
    Ohtsuka, Y
    Yamashiro, Y
    [J]. PEDIATRICS INTERNATIONAL, 2004, 46 (05) : 509 - 515
  • [7] Transforming growth factor-β as a regulator of site-specific T-cell inflammatory response
    Lúovíksson, BR
    Gunnlaugsdóttir, B
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 58 (02) : 129 - 138
  • [8] Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease
    Monteleone, G
    Kumberova, A
    Croft, NM
    McKenzie, C
    Steer, HW
    MacDonald, TT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (04) : 601 - 609
  • [9] Smad7:: a new key player in TGF-β-associated disease
    Nakao, A
    Okumura, K
    Ogawa, H
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (08) : 361 - 363
  • [10] Transforming growth factor-β:: an important cytokine in the mucosal immune response
    Ohtsuka, Y
    Sanderson, IR
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2000, 16 (06) : 541 - 545